Aptose Biosciences Inc. financial data

Symbol
APTOF on OTC
Location
Toronto
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 13 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 88% % -0.93%
Debt-to-equity -165% % 62%
Return On Equity 169% % -83%
Return On Assets -261% % 13%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2,552,429 shares -87%
Common Stock, Shares, Outstanding 2,552,429 shares -87%
Entity Public Float $22,075,799 USD -25%
Common Stock, Value, Issued $459,771,000 USD 1.7%
Weighted Average Number of Shares Outstanding, Basic 2,552,429 shares 316%
Weighted Average Number of Shares Outstanding, Diluted 2,552,429 shares 316%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $7,410,000 USD -65%
General and Administrative Expense $12,072,000 USD 4.8%
Nonoperating Income (Expense) $188,000 USD -53%
Net Income (Loss) Attributable to Parent $19,294,000 USD 46%
Earnings Per Share, Basic 2 USD/shares 82%
Earnings Per Share, Diluted 2 USD/shares 82%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $613,000 USD -92%
Cash, Cash Equivalents, and Short-term Investments $1,600,000 USD -80%
Other Assets, Current $127,000 USD -91%
Assets, Current $3,777,000 USD -63%
Property, Plant and Equipment, Net $8,000 USD -73%
Operating Lease, Right-of-Use Asset $277,000 USD -58%
Other Assets, Noncurrent $2,279,000 USD
Assets $6,341,000 USD -42%
Accounts Payable, Current $1,456,000 USD -20%
Employee-related Liabilities, Current $2,602,000 USD 197%
Accrued Liabilities, Current $4,804,000 USD -36%
Liabilities, Current $7,079,000 USD -27%
Operating Lease, Liability, Noncurrent $0 USD -100%
Liabilities $25,791,000 USD 29%
Accumulated Other Comprehensive Income (Loss), Net of Tax $4,316,000 USD 0%
Retained Earnings (Accumulated Deficit) $558,676,000 USD -3.6%
Stockholders' Equity Attributable to Parent $19,450,000 USD -113%
Liabilities and Equity $6,341,000 USD -42%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $27,009,000 USD 40%
Net Cash Provided by (Used in) Financing Activities $22,396,000 USD 20%
Net Cash Provided by (Used in) Investing Activities $2,009,000 USD -82%
Common Stock, Shares, Issued 2,552,429 shares -87%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $2,603,000 USD 83%
Deferred Tax Assets, Valuation Allowance $98,018,000 USD 7.4%
Deferred Tax Assets, Gross $98,018,000 USD 7.4%
Operating Lease, Liability $305,000 USD -58%
Depreciation $3,000 USD -81%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $21,124,000 USD 48%
Lessee, Operating Lease, Liability, to be Paid $314,000 USD -59%
Property, Plant and Equipment, Gross $544,000 USD -32%
Operating Lease, Liability, Current $305,000 USD -27%
Lessee, Operating Lease, Liability, to be Paid, Year Two $197,000 USD -57%
Lessee, Operating Lease, Liability, to be Paid, Year One $197,000 USD -57%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $9,000 USD
Deferred Tax Assets, Operating Loss Carryforwards $79,951,000 USD 8.7%
Operating Lease, Payments $457,000 USD -0.87%
Additional Paid in Capital $83,771,000 USD 1.8%
Depreciation, Depletion and Amortization $46,000 USD -53%
Deferred Tax Assets, Net of Valuation Allowance $0 USD
Share-based Payment Arrangement, Expense $491,000 USD -65%